| Name |
Ebrantil 25 mg otopina za injekciju/infuziju |
| Marketing Authorisation Number |
HR-H-898053873 |
| Active Substance |
urapidilklorid |
| Composition |
5 ml otopine za injekciju/infuziju sadrži 25 mg urapidila u obliku urapidilklorida |
| Pharmaceutical Form |
Otopina za injekciju / infuziju |
| Manufacturer |
Takeda Austria GmbH, Linz, Austrija |
| Marketing Authorisation Holder |
Cheplapharm Arzneimittel GmbH, Ziegelhof 24, Greifswald, Njemačka |
| Marketing Authorisation Date |
14.09.2022 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/14-02/506 |
| Registration Number |
381-12-01/70-22-70 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
C02CA06 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
